BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12110543)

  • 1. Compensatory glomerular growth after unilateral nephrectomy is VEGF dependent.
    Flyvbjerg A; Schrijvers BF; De Vriese AS; Tilton RG; Rasch R
    Am J Physiol Endocrinol Metab; 2002 Aug; 283(2):E362-6. PubMed ID: 12110543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High protein-induced glomerular hypertrophy is vascular endothelial growth factor-dependent.
    Schrijvers BF; Rasch R; Tilton RG; Flyvbjerg A
    Kidney Int; 2002 May; 61(5):1600-4. PubMed ID: 11967009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF-1, IGFBP-3, VEGF and MMP-9 levels and their potential relationship with renal functions in patients with compensatory renal growth.
    Yildiz B; Kural N; Colak O; Ak I; Akcar N
    Clin Physiol Funct Imaging; 2008 Mar; 28(2):107-12. PubMed ID: 18093232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes.
    Schrijvers BF; De Vriese AS; Tilton RG; Van de Voorde J; Denner L; Lameire NH; Flyvbjerg A
    Horm Metab Res; 2005 Jan; 37(1):21-5. PubMed ID: 15702434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor is an essential molecule for mouse kidney development: glomerulogenesis and nephrogenesis.
    Kitamoto Y; Tokunaga H; Tomita K
    J Clin Invest; 1997 May; 99(10):2351-7. PubMed ID: 9153276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compensatory renal growth in uninephrectomized adult mice is growth hormone dependent.
    Flyvbjerg A; Bennett WF; Rasch R; van Neck JW; Groffen CA; Kopchick JJ; Scarlett JA
    Kidney Int; 1999 Dec; 56(6):2048-54. PubMed ID: 10594780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [VEGF is an essential molecule for glomerular endothelial cells and its excretion in urine might be a unique marker of glomerular injury].
    Kitamoto Y; Tokunaga H; Miyamoto K; Tomita K
    Rinsho Byori; 2000 Jun; 48(6):485-90. PubMed ID: 10897664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compensatory kidney growth in estrogen receptor-alpha null mice.
    Sun J; Langer WJ; Devish K; Lane PH
    Am J Physiol Renal Physiol; 2006 Feb; 290(2):F319-23. PubMed ID: 16159896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive increase in kidney insulin-like growth factor I and initial renal enlargement in uninephrectomized-diabetic rats.
    Flyvbjerg A; Frystyk J; Marshall SM
    Horm Metab Res; 1990 Oct; 22(10):516-20. PubMed ID: 2079313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
    Plonowski A; Schally AV; Letsch M; Krupa M; Hebert F; Busto R; Groot K; Varga JL
    Prostate; 2002 Aug; 52(3):173-82. PubMed ID: 12111694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal effects of a neutralising RAGE-antibody in long-term streptozotocin-diabetic mice.
    Jensen LJ; Denner L; Schrijvers BF; Tilton RG; Rasch R; Flyvbjerg A
    J Endocrinol; 2006 Mar; 188(3):493-501. PubMed ID: 16522729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat.
    Schrijvers BF; Flyvbjerg A; Tilton RG; Lameire NH; De Vriese AS
    Nephrol Dial Transplant; 2006 Feb; 21(2):324-9. PubMed ID: 16249198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A murine vascular endothelial growth factor antibody inhibits in vivo growth of human Caki-I renal adenocarcinoma.
    Dagnaes-Hansen F; Rasmussen LM; Tilton R; Denner L; Flyvbjerg A
    Anticancer Res; 2003; 23(2B):1625-30. PubMed ID: 12820432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
    Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A
    Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biphasic expression of IGF-I following subtotal renal ablation.
    Muchaneta-Kubara EC; Cope GH; el Nahas AM
    Exp Nephrol; 1995; 3(3):165-72. PubMed ID: 7542538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crim1KST264/KST264 mice implicate Crim1 in the regulation of vascular endothelial growth factor-A activity during glomerular vascular development.
    Wilkinson L; Gilbert T; Kinna G; Ruta LA; Pennisi D; Kett M; Little MH
    J Am Soc Nephrol; 2007 Jun; 18(6):1697-708. PubMed ID: 17460146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver-derived IGF-I regulates kidney size, sodium reabsorption, and renal IGF-II expression.
    Svensson J; Tivesten A; Sjögren K; Isaksson O; Bergström G; Mohan S; Mölne J; Isgaard J; Ohlsson C
    J Endocrinol; 2007 Jun; 193(3):359-66. PubMed ID: 17535874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of transforming growth factor-beta1 and hypoxia-inducible factor-1alpha in an experimental model of kidney transplantation.
    Lario S; Mendes D; Bescós M; Iñigo P; Campos B; Alvarez R; Alcaraz A; Rivera-Fillat F; Campistol JM
    Transplantation; 2003 May; 75(10):1647-54. PubMed ID: 12777850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of early postnatal ibuprofen and indomethacin on VEGF, IGF-I, and GH during rat ocular development.
    Beharry KD; Modanlou HD; Hasan J; Gharraee Z; Abad-Santos P; Sills JH; Jan A; Nageotte S; Aranda JV
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3036-43. PubMed ID: 16799050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of vascular endothelial growth factor 165 drives peritumor interstitial convection and induces lymphatic drain: magnetic resonance imaging, confocal microscopy, and histological tracking of triple-labeled albumin.
    Dafni H; Israely T; Bhujwalla ZM; Benjamin LE; Neeman M
    Cancer Res; 2002 Nov; 62(22):6731-9. PubMed ID: 12438274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.